WORCESTER, Mass., Sept. 25, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has entered into an exclusive Product Licensing & Distribution Agreement with Adcock Ingram Limited and Adcock Ingram Healthcare (Pty) Ltd. (www.adcock.co.za) for the distribution of the Company's proprietary Glucose RapidSpray(tm) product in South Africa and six other neighboring countries. Adcock Ingram, part of the Tiger Brands Group, is a leading South African pharmaceutical company with an 11.4% share of the private healthcare market. Adcock Ingram has an extensive range of prescription, generic, and over-the-counter products and also provides life saving hospital equipment and diagnostic products and services.
